Gillette North Atlantic toiletries sales advance 9% in 1996.
This article was originally published in The Rose Sheet
Executive Summary
GILLETTE NORTH ATLANTIC TOILETRIES SALES UP 9% IN 1996, with profits advancing 10% for the year, the company reported during a Jan. 31 teleconference with securities analysts. In the fourth quarter, toiletries revenue for the North Atlantic Group (U.S., Canada and Western Europe) was also up about 10%. Profits for the quarter, however, "experienced a slight decline" due to "some unfavorable" product mix and promotional spending tied to the launch of the company's new Clear Stick antiperspirant and deodorant formulas for the Gillette Series and Right Guard brands
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.